Topic Editors

1. Department of Zootechnics, School of Sciences and Technology, University of Évora, Évora, Portugal
2. Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Vila Real, Portugal
Prof. Dr. Lúcio Lara Santos
Instituto Portugues de Oncologia de Francisco Gentil Porto, Porto, Portugal
1. Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
2. Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal

Prostate Cancer: Symptoms, Diagnosis & Treatment—3rd Edition

Abstract submission deadline
30 April 2026
Manuscript submission deadline
30 June 2026
Viewed by
3

Topic Information

Dear Colleagues,

This Topic is a continuation of the previous successful Topics "Prostate Cancer: Symptoms, Diagnosis and Treatment" (https://www.mdpi.com/topics/prostate_Cancer; https://www.mdpi.com/topics/prostate_Cancer2). The prostate is the largest accessory gland of the male reproductive tract. Together with seminal vesicles and bulbourethral glands, the prostate is responsible for producing an alkaline fluid that forms part of the seminal fluid. The prostates of men over 40 years of age are commonly affected by several pathologies, such as benign prostate hyperplasia and cancer. Prostate cancer is one of the most common cancers among the male population worldwide. According to the World Health Organization (WHO), in 2020, prostate cancer affected approximately 1.41 million men worldwide. Despite significant treatment improvements having been achieved with the advent of targeted and immune-checkpoint-inhibitor-based therapies, cancer remains a primary causes of death worldwide. Therefore, this Topic will consider articles on all types of research on prostate cancer, including in vitro and in vivo approaches. Research on the impacts of the tumor macroenvironment (microbiota, diet, physical exercise) on tumor biology, as well as review studies, is also welcome. We invite scientists to publish their excellent work in one of the following journals: Cancers, Diagnostics or Medicina.

Dr. Ana Faustino
Prof. Dr. Lúcio Lara Santos
Prof. Dr. Paula Oliveira
Topic Editors

Keywords

  • cancer biology
  • in vitro
  • in vivo
  • resistance
  • treatment

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cancers
cancers
4.5 8.0 2009 17.4 Days CHF 2900 Submit
Diagnostics
diagnostics
3.0 4.7 2011 20.3 Days CHF 2600 Submit
Medicina
medicina
2.4 3.3 1920 17.1 Days CHF 2200 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

This Topic is now open for submission.
Back to TopTop